Cited by 107Autism Spectrum Disorder ResearchGenetics and Neurodevelopmental DisordersNeurotransmitter Receptor Influence on Behavior

Increased serotonin axons (immunoreactive to 5-HT transporter) in postmortem brains from young autism donors

Azmitia, Efrain C., Singh, Jorawer S., Whitaker-Azmitia, Patricia M.·2011·Neuropharmacology

Abstract

Imaging studies of serotonin transporter binding or tryptophan retention in autistic patients suggest that the brain serotonin system is decreased. However, treatment with drugs which increase serotonin (5-HT) levels, specific serotonin reuptake inhibitors (SSRIs), commonly produce a worsening of the symptoms. In this study we examined 5-HT axons that were immunoreactive to a serotonin transporter (5-HTT) antibody in a number of postmortem brains from autistic patients and controls with no known diagnosis who ranged in age from 2 to 29 years. Fine, highly branched, and thick straight fibers were found in forebrain pathways (e.g. medial forebrain bundle, stria terminalis and ansa lenticularis). Many immunoreactive varicose fine fibers were seen in target areas (e.g. globus pallidus, amygdala and temporal cortex). Morphometric analysis of the stained axons at all ages studied indicated that the number of serotonin axons was increased in both pathways and terminal regions in cortex from autism donors. Our findings provide morphological evidence to warrant caution when using serotonin enhancing drugs (e.g. SSRIs and receptor agonist) to treat autistic children. This article is part of a Special Issue entitled 'Trends in neuropharmacology: in memory of Erminio Costa'.

Integrity signals

Registry

Crossref · 10.1016/j.neuropharm.2011.02.002

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Increased numbers of 5-HT axons and terminals were reported in various brain regions via immunocytochemical labeling of 5-HT transporter in post-mortem autism subjects aged 2-29, questioning wide use of SSRIs as therapeutic agents.

    “An increased number of 5-HT axons and terminals were reported in a variety of brain regions via immunocytochemical labeling of 5-HT transporter in post-mortem autism subjects aged 2–29 years old bringing into question the wide use of SSRIs as therapeutic agents [187].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Azmitia, E. C., Singh, J. S., & Whitaker-Azmitia, P. M.
Affiliations
New York University (US)
Corresponding author
Azmitia, Efrain C.
Venue
Neuropharmacology
Publisher
Elsevier BV
Published
2011-06
Volume
60
Issue
7-8
Pages
1347-1354
ISSN
0028-3908 (ISSN-L)
OpenAlex
W1999133104
Cited by
107
References
53
Citations by year
2025: 6 · 2024: 4 · 2023: 3 · 2022: 4 · 2021: 5 · 2020: 10 · 2019: 6 · 2018: 8 · 2017: 6 · 2016: 8 · 2015: 8 · 2014: 11 · 2013: 13 · 2012: 9
FWCI
6.15
Type
journal article
Language
en
Open access
closed
Locations
  • Neuropharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
autism spectrum disorder, serotonin, serotonin transporter, serotonergic system, serotonin reuptake inhibitors, SSRI adverse effects, autism pharmacotherapy, postmortem brain, axon morphology, medial forebrain bundle, stria terminalis, ansa lenticularis, globus pallidus, amygdala, temporal cortex
MeSH terms
Adolescent, Adult, Autistic Disorder, Autopsy, Axons, Brain, Child, Child, Preschool, Female, Globus Pallidus, Humans, Male, Medial Forebrain Bundle, Nerve Fibers, Serotonin, Temporal Lobe, Prosencephalon, Subthalamus, Serotonin Plasma Membrane Transport Proteins, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review